Knee Osteoarthritis
Conditions
Keywords
pain modulation, mind-body exercise
Brief summary
The goal of this clinical trial is to compare a pain informed movement program to standard neuromuscular exercise in people with knee osteoarthritis. The main question it aims to answer are: 1. Are the two interventions a) pain informed movement program plus pain neuroscience education and b) neuromuscular exercise plus standard osteoarthritis education feasible in terms of recruitment, treatment adherence, timelines, data collection procedures, patient follow-up, and resources required? 2. Is there a difference in patient's satisfaction and acceptability of the two programs? 3. Are there any differences in the potential effects of the two programs on subjective pain measures, self-reported function, quality of life, functional leg strength, nervous system pain modulation, brain derived neurotrophic factor and nerve growth factor levels, and psychological factors?
Detailed description
It is critical to understand the underlying mechanism of knee osteoarthritis (OA) pain in order to effectively manage knee OA. It has become clear that alterations in central and peripheral nervous system functioning occurs in people with knee OA and pain sensitization is a common feature. Descending modulation from the central nervous system can facilitate or inhibit nociception. Endogenous pain modulation through the descending system is an important factor as its dysregulation has significant ramifications in pain facilitation and promotion of chronic pain development and maintenance at all levels of the nervous system. The current guidelines lack focus on how to effectively manage it, which is a potential reason for why the current methods in conservative management of knee OA pain are only moderately effective. Mind-body approaches are uniquely positioned to potentially reverse the sensitization, induce positive neuroplastic changes, and improve descending pain modulation resulting in decreased pain intensity in many chronic pain populations. This study involves an exercise program which the investigators call 'Pain Informed Movement' that includes evidence-based exercises combined with mind-body techniques and pain neuroscience education. The data from this phase will be used to inform a multi-site randomized controlled trial (RCT) to assess the program's effectiveness with the primary outcome of change in pain severity mediated by change in descending pain modulation. Exercise is regularly used as a first-line management option for knee OA, and its use is supported by high quality evidence to improve pain and function. Clinical practice guidelines for people with knee OA recommend the use of aerobic and strength training for the reduction of pain and improved physical function. Currently, one of the key components of conservative management of knee OA often implemented by clinicians is a type of exercise called neuromuscular exercise, which aims at improving sensorimotor control and the functionality of the knee joint by addressing movement in all three movement planes. Previous research has showed that the neuromuscular exercise programs designed specifically for knee OA can reduce pain, improve function, alter knee biomechanics, and improve the muscle-activation patterns of the surrounding knee musculature. While exercise is the first line treatment for knee OA and can lead to improvements in physical function and pain, it is important to highlight that it has a moderate effect, which may be short term. In recent years multiple guidelines for non-surgical management of knee OA have begun to include mind-body therapies, such as yoga or tai-chi, as conditional or core treatment recommendations. Mind-body therapies can lead to pain reductions and improvement of function through various techniques. For instance, breathing exercises including breath awareness and regulation can activate the parasympathetic nervous system and decrease the danger signals of pain, leading to improvement of pain levels. Meditative breathing can lead to reductions in pain levels by modulating the somatosensory cortex. Relaxation techniques focused on relaxing the muscles that become tense as a result of pain and by association can re-enforce or aggravate pain, can influence the pain experience by reversing that association. Mindfulness meditation and mindful movement which can lead to a switch from sensory pain to the interoceptive awareness of the movements of the different body parts, resulting in reduced muscle tension, improvements in postural stability and proprioception, and reductions in pain levels. Mind-body therapies also lead to improvement of psychological factors such as depression, anxiety, pain catastrophizing, increasing pain acceptance, changing patients' relationships to their pain, which in turn lead to reductions in pain levels. The positive effects of mindfulness practices have been reported to last in longer-term follow ups such as 15 months, and 3 years. Education is another core component recommended by clinical guidelines and known to be effective particularly when combined with exercise. Pain Neuroscience education (PNE) is an alternative technique of teaching patients about pain and how to rethink and re-evaluate the way pain is viewed. The use of PNE in physical therapy interventions has been steadily increasing due to its positive effects on pain and function in many chronic pain patient populations. PNE includes an explanation of the neurophysiology of pain and its process by the nervous system. This includes how pain can be modulated through upregulation or downregulation of signals to increase or decrease the pain experience and that these changes are not necessarily related to tissue damage, particularly when pain becomes chronic. PNE also provides information regarding the influence of various psychosocial aspects. By offering avenues to reconceptualize pain as a threat to the body and movement as imminent danger, patients may become more willing to participate in physical activity and tolerate slight increases in pain and discomfort. In contrast standard OA education is the traditional and most widely used educational model in people with knee OA, focuses heavily on a pathoanatomical perspective of pain referring mainly to anatomy, biomechanics, and patho-anatomy of OA and the knee joint. Given the importance of finding effective management strategies for pain modulation in people with knee OA, there is a need to further our understanding of the impact of evidence-based exercise combined with mind-body techniques (e.g., breathing exercises and mindfulness) with PNE on pain mechanisms. The study is a pilot RCT with a nested qualitative component. The study will be guided by the Conceptual Framework for Defining Feasibility and Pilot studies and the Standard Protocol Items: Recommendations for Intervention Trials. Study Population A sample of 66 adults will be sought. The sample size is based on the primary outcome of complete follow-up using the confidence interval method for calculating sample size in pilot trials. 90% follow-up rate is the aim but the trial will be considered successful if 81% is achieved. To achieve a margin of error of 9%, with 10% added for attrition, 66 participants is required. Recruitment Participants will be recruited through the email lists of the McMaster Physical Activity Centre of Excellence (PACE) community and the McMaster Institute for Research on Aging (MIRA) newsletter. Postings will be placed on both PACE and MIRA social media pages. In addition, the study poster will be placed on other social media channels (i.e., Twitter, Facebook advertisements). In addition, flyers will be placed in local orthopaedic surgeon, Rheumatologist and Physiatrists offices. Physicians will provide potential participants with a one-page study information sheet in lay language. If interested, potential participants can then contact the research team through the contact information provided in the flyer. Setting The in-person 8-week exercise program will be held twice weekly at McMaster University's Physical Activity Centre of Excellence (PACE) located in the Ivor-Wynne Centre or in one of two local community churches. Participants will complete the pain assessment, and have blood drawn at PACE by PACE staff who are certified phlebotomists. Assessment As part of participation in the study, participants will be asked to attend an assessment at the beginning of the study, and once again upon completing the 8-week exercise program. Participants will conditioned undergo pain modulation (CPM) and mechanical temporal summation testing, and the 30 Second Sit to Stand Test to determine leg strength and endurance. Lastly, participants will have their blood drawn (fasting) at the beginning and end of the study. Participants will then be asked to complete a series of questionnaires about their pain and mood. Interventions Twice weekly group exercise sessions will be 75 minutes for the intervention group and 60 minutes in duration for the control group. The intervention arm class is slightly longer due to the detailed delivery of instructions for the techniques during the class. Participants will be given instructions to complete these exercises at home at least one other time during the week for the same duration. Participants will receive education videos that are \ 15-20 minutes each week, for up to 4 weeks. Pain Informed Movement and PNE - During the neuromuscular exercise sessions, the PNE components and concepts such as mindfulness, muscle tension regulation, and breathing techniques will be applied by the instructor. Neuromuscular exercise and standard OA education - The exercise component (i.e., the specific movements) of this group will be similar to those of the intervention group without the added mind-body techniques. Randomization and allocation concealment Participants will be randomized with an allocation ratio of 1:1 into one of two treatment groups (Pain informed movement and PNE versus neuromuscular exercise and standard OA education) using a REDCap randomization module. Following consent and completion of baseline assessment, the assessor (different person than the recruiter) will log in to the website, open the participants' identification record and click on the randomize button. Randomization will be blocked and this process will ensure allocation concealment. As allocation concealment occurs following the baseline assessment, the assessors will be blinded at baseline and follow up assessment. Blinding of instructors is generally not possible in studies of physical interventions (i.e., exercise). Participants will be blinded to study hypotheses and the two treatment groups. As both arms of the study are providing exercise based interventions and education, participants will be provided limited details of each intervention arm so as to blind them from knowing which is the intervention and which is the control. This will help minimize any bias that occurs by knowledge of group assignment and perception of treatment effects. Exit Survey and Focus Group In addition to the primary and secondary outcomes, a satisfaction survey will be conducted at the end of the program to evaluate the a priori feasibility criteria. Participants who indicated upon initially consenting to the study that would like to participate in a focus group, will be contacted. Qualitative data collection will be used to explore participants experience and perceptions of the feasibility and acceptability of the program. A focus group will be conducted using audio or video recording (using Zoom), lasting between 45-60 minutes.
Interventions
group classes twice weekly for 8 weeks of neuromuscular exercise in combination with mind-body techniques such as breath regulation, muscle tension regulation, relaxation, mindfulness, awareness of pain related thoughts and emotions.
group classes twice weekly for 8 weeks of neuromuscular exercise.
The pain neuroscience education (PNE) will be delivered in videos addressing concepts such as the purpose of pain, neurophysiological changes of pain, movement guidelines when pain persists, and self-care techniques to impact neurophysiology and support moving with ease that include breath awareness and regulation, muscle tension regulation, awareness of pain related thoughts and emotions, relaxation, and body awareness.
The standard osteoarthritis (OA) education will address the following topics, OA prevalence, risk factors, symptoms, diagnosis, treatment, role of exercise, surgery, self-management
Sponsors
Study design
Eligibility
Inclusion criteria
* \- ≥40 years of age with diagnosis of knee osteoarthritis (OA) by a physician OR; * ≥45 years of age and having activity-related knee joint pain with or without morning stiffness lasting 30 minutes (NICE criteria) * Having an average pain intensity of 3/10 on a numeric pain scale on most days of the past month
Exclusion criteria
* Cannot communicate in English; * Has inflammatory arthritis or other systemic conditions; * Have had lower limb trauma or surgery within the past 6 months; * Have participated in a knee OA exercise program in the prior 3 months; * Have had any injection in the index knee within 3-months prior to baseline assessment * Does not have regular access to the internet * Inability to get up and down from the floor independently * Use of mobility aids * Currently participating in any other drug/device/exercise clinical trial related to OA * Planned absences (e.g., trips away) of \>1 week * Currently receiving other forms of care for knee OA pain (e.g., from a physiotherapist, chiropractor, athletic therapist, kinesiologist) * Does not meet screening for safe participation in exercise according to the Get Active questionnaire from the Canadian Society for Exercise Physiology
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Follow up | 8 weeks | The follow-up rate is calculated as the number (percentage) of participants who completed the study out of those who completed the baseline assessment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Who Considered the Program Frequent Enough | 8 weeks | This outcome measure represents the number of participants who rated the program's frequency as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, capturing participants' satisfaction with the program's scheduling. |
| Number of Participants Who Considered the Educational Session Frequency Enough | 8 weeks | This outcome measure represents the number of participants who rated the frequency of the educational sessions as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, assessing participants' satisfaction with the scheduling of the sessions. |
| Rate of Recruitment Measured by Number of People Recruited in a Year | 1 year | recruitment rate is a minimum of 40 people in a year |
| Number of Participants Who Considered the Program Useful and Very Useful | 8 weeks | the number of participants who found the program useful or very useful. Participants rated the program's usefulness on a Likert scale, ranging from Not useful at all to Very useful. The final count reflects those who selected either of the top two response categories, indicating a positive perception of the program's value. |
| Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed | 8 weeks | This outcome measure evaluates adherence to the program by calculating the number of sessions attended in-person and the number of home sessions completed by participants. The rate of adherence is determined by the proportion of sessions attended and completed relative to the total number of scheduled sessions. |
| Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment | 8 weeks | measured as any problem that lasts for \>2 days and/or causes the participant to seek other treatment |
| Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale | 8 weeks | This outcome measure represents the percentage of participants who rated the program's burdensomeness as zero, using a scale from 0 (No burden at all) to 10 (Very much a burden). Participants who provided a low burden rating (≤3/10) are included in this percentage, indicating that they did not perceive the program as burdensome. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Pain Intensity Measured on the Numeric Rating Scale (NRS) | baseline and 8 weeks | This outcome measure assesses pain intensity using the Numeric Rating Scale (NRS), where participants rate their pain on a scale from 0 to 10, with higher scores indicating greater pain severity. Three ratings are recorded: average pain intensity in the past 24 hours, average pain intensity in the past week, and worst pain intensity in the past 24 hours. |
| Pain Catastrophizing Scale (PCS) | baseline and 8 weeks | 13 questions for a total score of 52 with higher scores indicating more severe symptoms. Minimum score = 0, maximum score 52 |
| Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6) | baseline and 8 weeks | measure of self-efficacy rated on 0-10 scale ranging from not at all confident to entirely confident |
| Hospital Anxiety and Depression Scale (HADS) | baseline and 8 weeks | This outcome measure assesses symptoms of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 14 items, with seven items assessing anxiety (HADS-A) and seven assessing depression (HADS-D). Each item is scored on a 0 to 3 scale, resulting in total scores ranging from 0 to 21 for both anxiety and depression subscales. Higher scores indicate greater levels of anxiety or depression, |
| Brief Fear of Movement Scale for Osteoarthritis (BFMSO) | Baseline and 8 weeks | This outcome measure assesses fear of movement (kinesiophobia) in individuals with osteoarthritis using the Brief Fear of Movement Scale for Osteoarthritis (BFMSO). The BFMSO consists of six items derived from the Tampa Scale for Kinesiophobia (TSK) and is rated on a 4-point Likert scale (1-4), with a total score range of 6 to 24, where higher scores indicate greater levels of kinesiophobia. The scale evaluates concerns about movement due to pain or the fear of worsening symptoms, providing insight into the psychological barriers that may affect physical activity and rehabilitation adherence in individuals with osteoarthritis. |
| Modified Charlson Comorbidity Index | baseline | to assesses the presence of comorbidities minimum score = 0, maximum = 20 with higher scores indicating greater severity. |
| Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | baseline and 8 weeks | The ICOAP (Intermittent and Constant Osteoarthritis Pain) Knee Version assesses two distinct types of knee pain: constant pain and intermittent pain. The constant pain subscale consists of five items that evaluate pain that is present all the time. Each item is rated on a scale from 0 to 4, where 0 represents no pain, 1 indicates mild pain, 2 corresponds to moderate pain, 3 signifies severe pain, and 4 represents extreme pain. The total score for this subscale ranges from 0 to 20, with higher scores reflecting greater pain severity. Similarly, the intermittent pain subscale comprises six items that assess pain that comes and goes in episodes. Each item follows the same 0 to 4 rating scale, capturing the intensity of episodic pain experiences. The total score for this subscale ranges from 0 to 24. The overall ICOAP knee score is the sum of both subscales, resulting in a total score range of 0 to 44, where higher scores indicate more severe and impactful knee pain. |
| 30 Second Sit to Stand Test | baseline and 8 weeks | to measure functional leg strength and endurance by counting the numbers of complete movements accomplished in the allotted time |
| Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis | baseline and 8 weeks | a neurotrophin level measured in pg/ml |
| Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis | baseline and 8 weeks | a neurotrophin level measured in pg/ml |
| Perspectives on the Effectiveness of the Different Intervention Components on Managing Pain | 8 weeks | One question will be asked of participants in each arm to rank the effectiveness of the different components of the intervention they received. e.g. Please rank the different components of the intervention you received in order of how effective they are for managing your pain. A list of the different components in each study arm will be provided e.g. education videos, strengthening exercise, mind-body techniques |
| Knee Injury and Osteoarthritis Outcome Score (KOOS) | baseline and 8 weeks | The KOOS pain and function in daily living and QoL subscales were used to assess self-reported opinions about patients' knee and associated problems. Scores ranged from 0-100 with zero representing extreme knee problems and 100 representing no knee problems |
| Participant Characteristics | baseline | Ethnicity |
| Weight | baseline and 8 weeks | Weight |
| Number of Participants With Medication Use | baseline and 8 weeks | This outcome measure represents the number of participants who reported taking any medication on a regular schedule. Medication use was assessed with a yes/no response, where participants indicated whether they consistently take any prescribed or over-the-counter medications. |
| Perspectives on Knee Replacement Surgery | baseline and 8 weeks | Three questions will be asked: 1. Are your knee symptoms so severe that you wish to undergo knee replacement surgery? 2. Do you think knee replacement surgery is eventually inevitable? 3. In your opinion, what factor(s) can lead to better outcomes after knee replacement surgery? |
| Other Painful Body Parts | baseline and 8 weeks | Using a body diagram, participants will be asked to indicate any other areas where they experience pain |
| Mechanical Temporal Summation (TS) | baseline and 8 weeks | A 512mN weighted probe was applied at the volar wrist opposite to the index knee. Participants were asked to rate their pain on a scale from 0 (no pain) to 100 (worst imaginable pain). Then, the same stimulus was applied 10 times at a rate of 1 per second (guided by a metronome), and participants were again asked to rate their pain. Temporal Summation (TS) was defined as present if the pain rating after the repeated stimuli was higher than the initial pain rating. The TS score was calculated as the difference between the pain rating after the repeated stimuli and the initial pain rating at each timepoint. |
| Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia | baseline and 8 weeks | First stimulus of pressure pain threshold is delivered, next ischemic forearm test is conducted to a 4/10 and then PPT is repeated. An index will be created by calculating the percent efficiency of CPM (%CPM) as PPT2/PPT1, multiplied by 100; whereby %CPM ≤ 100 indicates inefficient pain modulation CPM. There are no standard minimum or maximum values. |
Countries
Canada
Participant flow
Pre-assignment details
NA. we did not have any significant event prior to assignment of participants to an arm.
Participants by arm
| Arm | Count |
|---|---|
| Pain Informed Movement and Pain Neuroscience Education Participants will engage in a twice-weekly, 8-week in-person group exercise program, combining neuromuscular exercise and mind-body techniques. Each session includes 75 minutes of exercise instruction and, during the first four weeks, 20 to 30 minutes of Pain Neuroscience Education (PNE) videos. A third weekly home session will be supported by exercise handouts. The exercise component will be led by an experienced yoga instructor trained extensively in pain-informed movement, incorporating techniques such as breath regulation, muscle tension regulation, relaxation, mindfulness, and awareness of pain-related thoughts and emotions.
The PNE videos will cover key topics: the purpose of pain, neurophysiological changes in pain, movement strategies when pain persists, and self-care techniques to influence neurophysiology. These include breath awareness, muscle tension regulation, and relaxation methods aimed at supporting movement with greater ease while fostering body awareness and emotional regulation. | 28 |
| Standard Neuromuscular Exercise and OA Education Participants in this group will receive an 8-week in-person group exercise program held twice weekly, in which they will receive exercise instructions (60 minutes) and standard osteoarthritis (OA) education (15 to 20 minutes/week for the first 4 weeks). A third home session (weekly) will be facilitated by exercise handout sheets. The exercise component (i.e., the specific movements) of this group will be similar to those of the other group without the added techniques of breath awareness and regulation, muscle tension regulation, awareness of pain related thoughts and emotions, relaxation, and body awareness. The standard OA education videos will cover the following topics: common OA symptoms, risk factors associated with knee OA, and the effects of exercise and self-management tips. The exercise and education components will be delivered by a physiotherapist in the research team.
standard neuromuscular exercise: group classes twice weekly for 8 weeks of neuromuscular exercise.
Standard osteoarthritis (OA) education: The standard osteoarthritis (OA) education will address the following topics, OA prevalence, risk factors, symptoms, diagnosis, treatment, role of exercise, surgery, self-management | 31 |
| Total | 59 |
Baseline characteristics
| Characteristic | Standard Neuromuscular Exercise and OA Education | Total | Pain Informed Movement and Pain Neuroscience Education |
|---|---|---|---|
| Age, Continuous | 62 years STANDARD_DEVIATION 10 | 63 years STANDARD_DEVIATION 10 | 64 years STANDARD_DEVIATION 9 |
| Race (NIH/OMB) American Indian or Alaska Native | 28 Participants | 53 Participants | 25 Participants |
| Race (NIH/OMB) Asian | 2 Participants | 4 Participants | 2 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 1 Participants | 2 Participants | 1 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 0 Participants | 0 Participants | 0 Participants |
| Sex: Female, Male Female | 19 Participants | 42 Participants | 23 Participants |
| Sex: Female, Male Male | 12 Participants | 17 Participants | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 34 | 0 / 35 |
| other Total, other adverse events | 0 / 34 | 0 / 35 |
| serious Total, serious adverse events | 0 / 34 | 0 / 35 |
Outcome results
Percentage of Follow up
The follow-up rate is calculated as the number (percentage) of participants who completed the study out of those who completed the baseline assessment.
Time frame: 8 weeks
Population: This is the number of participants at baseline who completed the baseline assessments and enrolled in the study.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Percentage of Follow up | 28 Participants |
| Standard Neuromuscular Exercise and OA Education | Percentage of Follow up | 31 Participants |
Number of Participants Who Considered the Educational Session Frequency Enough
This outcome measure represents the number of participants who rated the frequency of the educational sessions as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, assessing participants' satisfaction with the scheduling of the sessions.
Time frame: 8 weeks
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Number of Participants Who Considered the Educational Session Frequency Enough | 24 Participants |
| Standard Neuromuscular Exercise and OA Education | Number of Participants Who Considered the Educational Session Frequency Enough | 25 Participants |
Number of Participants Who Considered the Program Frequent Enough
This outcome measure represents the number of participants who rated the program's frequency as Frequent enough on a 5-point Likert scale. The scale ranged from Not frequent enough to Frequent enough, capturing participants' satisfaction with the program's scheduling.
Time frame: 8 weeks
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Number of Participants Who Considered the Program Frequent Enough | 24 Participants |
| Standard Neuromuscular Exercise and OA Education | Number of Participants Who Considered the Program Frequent Enough | 25 Participants |
Number of Participants Who Considered the Program Useful and Very Useful
the number of participants who found the program useful or very useful. Participants rated the program's usefulness on a Likert scale, ranging from Not useful at all to Very useful. The final count reflects those who selected either of the top two response categories, indicating a positive perception of the program's value.
Time frame: 8 weeks
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Number of Participants Who Considered the Program Useful and Very Useful | 25 Participants |
| Standard Neuromuscular Exercise and OA Education | Number of Participants Who Considered the Program Useful and Very Useful | 29 Participants |
Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale
This outcome measure represents the percentage of participants who rated the program's burdensomeness as zero, using a scale from 0 (No burden at all) to 10 (Very much a burden). Participants who provided a low burden rating (≤3/10) are included in this percentage, indicating that they did not perceive the program as burdensome.
Time frame: 8 weeks
Population: The percentage of the participants per arm who did not find the study procedures burdensome.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale | Burden of questionnaires | 69 percentage of the participants |
| Pain Informed Movement and Pain Neuroscience Education | Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale | Burden of physical assessments | 83 percentage of the participants |
| Standard Neuromuscular Exercise and OA Education | Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale | Burden of questionnaires | 87 percentage of the participants |
| Standard Neuromuscular Exercise and OA Education | Percentage of Participants Who Did Not Find the Study Procedures Burdensome (Questionnaires, Tests, Blood Draws) Measured on 0-10 Scale | Burden of physical assessments | 94 percentage of the participants |
Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed
This outcome measure evaluates adherence to the program by calculating the number of sessions attended in-person and the number of home sessions completed by participants. The rate of adherence is determined by the proportion of sessions attended and completed relative to the total number of scheduled sessions.
Time frame: 8 weeks
Population: This is the total number of possible sessions for each group (16 sessions \* Number of participants per group)
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed | 396 number of sessions attended in each grou |
| Standard Neuromuscular Exercise and OA Education | Rate of Adherence Measured by Number of Sessions Attended and Home Sessions Completed | 425 number of sessions attended in each grou |
Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment
measured as any problem that lasts for \>2 days and/or causes the participant to seek other treatment
Time frame: 8 weeks
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment | 0 Number of adverse events |
| Standard Neuromuscular Exercise and OA Education | Rate of Adverse Events Measured by Question Regarding Symptom Flare and Seeking Treatment | 0 Number of adverse events |
Rate of Recruitment Measured by Number of People Recruited in a Year
recruitment rate is a minimum of 40 people in a year
Time frame: 1 year
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Rate of Recruitment Measured by Number of People Recruited in a Year | 28 Participants |
| Standard Neuromuscular Exercise and OA Education | Rate of Recruitment Measured by Number of People Recruited in a Year | 31 Participants |
30 Second Sit to Stand Test
to measure functional leg strength and endurance by counting the numbers of complete movements accomplished in the allotted time
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | 30 Second Sit to Stand Test | Baseline | 13.8 repetitions | Standard Deviation 3.3 |
| Pain Informed Movement and Pain Neuroscience Education | 30 Second Sit to Stand Test | Follow-up | 17 repetitions | Standard Deviation 4 |
| Standard Neuromuscular Exercise and OA Education | 30 Second Sit to Stand Test | Baseline | 11.9 repetitions | Standard Deviation 2.6 |
| Standard Neuromuscular Exercise and OA Education | 30 Second Sit to Stand Test | Follow-up | 15 repetitions | Standard Deviation 4 |
Brief Fear of Movement Scale for Osteoarthritis (BFMSO)
This outcome measure assesses fear of movement (kinesiophobia) in individuals with osteoarthritis using the Brief Fear of Movement Scale for Osteoarthritis (BFMSO). The BFMSO consists of six items derived from the Tampa Scale for Kinesiophobia (TSK) and is rated on a 4-point Likert scale (1-4), with a total score range of 6 to 24, where higher scores indicate greater levels of kinesiophobia. The scale evaluates concerns about movement due to pain or the fear of worsening symptoms, providing insight into the psychological barriers that may affect physical activity and rehabilitation adherence in individuals with osteoarthritis.
Time frame: Baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Brief Fear of Movement Scale for Osteoarthritis (BFMSO) | Baseline | 10.3 Total score on a scale | Standard Deviation 2.7 |
| Pain Informed Movement and Pain Neuroscience Education | Brief Fear of Movement Scale for Osteoarthritis (BFMSO) | Follow-up | 11.8 Total score on a scale | Standard Deviation 2.1 |
| Standard Neuromuscular Exercise and OA Education | Brief Fear of Movement Scale for Osteoarthritis (BFMSO) | Baseline | 10.4 Total score on a scale | Standard Deviation 3.1 |
| Standard Neuromuscular Exercise and OA Education | Brief Fear of Movement Scale for Osteoarthritis (BFMSO) | Follow-up | 10.7 Total score on a scale | Standard Deviation 3.1 |
Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia
First stimulus of pressure pain threshold is delivered, next ischemic forearm test is conducted to a 4/10 and then PPT is repeated. An index will be created by calculating the percent efficiency of CPM (%CPM) as PPT2/PPT1, multiplied by 100; whereby %CPM ≤ 100 indicates inefficient pain modulation CPM. There are no standard minimum or maximum values.
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia | Baselin | 110.4 score on a scale | Standard Deviation 23.7 |
| Pain Informed Movement and Pain Neuroscience Education | Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia | Follow-up | 120 score on a scale | Standard Deviation 33.4 |
| Standard Neuromuscular Exercise and OA Education | Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia | Baselin | 102.2 score on a scale | Standard Deviation 34.7 |
| Standard Neuromuscular Exercise and OA Education | Conditioned Pain Modulation (CPM) Measured With PPT Test Stimulus and Conditioning Stimulus of Forearm Ischemia | Follow-up | 109.1 score on a scale | Standard Deviation 32.2 |
Hospital Anxiety and Depression Scale (HADS)
This outcome measure assesses symptoms of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). The HADS consists of 14 items, with seven items assessing anxiety (HADS-A) and seven assessing depression (HADS-D). Each item is scored on a 0 to 3 scale, resulting in total scores ranging from 0 to 21 for both anxiety and depression subscales. Higher scores indicate greater levels of anxiety or depression,
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Hospital Anxiety and Depression Scale (HADS) | Anxiety Baseline | 5.2 score on a scale | Standard Deviation 3.2 |
| Pain Informed Movement and Pain Neuroscience Education | Hospital Anxiety and Depression Scale (HADS) | Depression Baseline | 3.6 score on a scale | Standard Deviation 2.3 |
| Pain Informed Movement and Pain Neuroscience Education | Hospital Anxiety and Depression Scale (HADS) | Anxiety Follow-up | 5.2 score on a scale | Standard Deviation 3.1 |
| Pain Informed Movement and Pain Neuroscience Education | Hospital Anxiety and Depression Scale (HADS) | Depression follow-up | 3.7 score on a scale | Standard Deviation 2.3 |
| Standard Neuromuscular Exercise and OA Education | Hospital Anxiety and Depression Scale (HADS) | Depression follow-up | 3.8 score on a scale | Standard Deviation 2.9 |
| Standard Neuromuscular Exercise and OA Education | Hospital Anxiety and Depression Scale (HADS) | Anxiety Baseline | 4.9 score on a scale | Standard Deviation 3 |
| Standard Neuromuscular Exercise and OA Education | Hospital Anxiety and Depression Scale (HADS) | Anxiety Follow-up | 4.2 score on a scale | Standard Deviation 3.6 |
| Standard Neuromuscular Exercise and OA Education | Hospital Anxiety and Depression Scale (HADS) | Depression Baseline | 4.9 score on a scale | Standard Deviation 3 |
Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version
The ICOAP (Intermittent and Constant Osteoarthritis Pain) Knee Version assesses two distinct types of knee pain: constant pain and intermittent pain. The constant pain subscale consists of five items that evaluate pain that is present all the time. Each item is rated on a scale from 0 to 4, where 0 represents no pain, 1 indicates mild pain, 2 corresponds to moderate pain, 3 signifies severe pain, and 4 represents extreme pain. The total score for this subscale ranges from 0 to 20, with higher scores reflecting greater pain severity. Similarly, the intermittent pain subscale comprises six items that assess pain that comes and goes in episodes. Each item follows the same 0 to 4 rating scale, capturing the intensity of episodic pain experiences. The total score for this subscale ranges from 0 to 24. The overall ICOAP knee score is the sum of both subscales, resulting in a total score range of 0 to 44, where higher scores indicate more severe and impactful knee pain.
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Constant Pain - Baseline | 6.9 score on a scale | Standard Deviation 3.3 |
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Intermittent Pain- Baseline | 10.2 score on a scale | Standard Deviation 4 |
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Constant Pain - Follow-up | 4.4 score on a scale | Standard Deviation 3.4 |
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Intermittent Pain- Follow up | 7.5 score on a scale | Standard Deviation 4.2 |
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Total Score Baseline | 17.2 score on a scale | Standard Deviation 6.3 |
| Pain Informed Movement and Pain Neuroscience Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Total Score Follow up | 11.8 score on a scale | Standard Deviation 7.3 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Total Score Baseline | 16.1 score on a scale | Standard Deviation 7.1 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Constant Pain - Baseline | 5.5 score on a scale | Standard Deviation 3.9 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Intermittent Pain- Follow up | 7 score on a scale | Standard Deviation 3.8 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Intermittent Pain- Baseline | 10.4 score on a scale | Standard Deviation 3.6 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Total Score Follow up | 11.1 score on a scale | Standard Deviation 6.7 |
| Standard Neuromuscular Exercise and OA Education | Intermittent and Constant Osteoarthritis Pain (ICOAP) Knee Version | Constant Pain - Follow-up | 4.2 score on a scale | Standard Deviation 3.7 |
Knee Injury and Osteoarthritis Outcome Score (KOOS)
The KOOS pain and function in daily living and QoL subscales were used to assess self-reported opinions about patients' knee and associated problems. Scores ranged from 0-100 with zero representing extreme knee problems and 100 representing no knee problems
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Pain baseline | 55.3 score on a scale | Standard Deviation 12.7 |
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Function baseline | 70.5 score on a scale | Standard Deviation 12.1 |
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | QL baseline | 23.6 score on a scale | Standard Deviation 15.9 |
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Pain follow-up | 67.4 score on a scale | Standard Deviation 13.5 |
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Function follow-up | 77.2 score on a scale | Standard Deviation 12.1 |
| Pain Informed Movement and Pain Neuroscience Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Ql- follow up | 28.1 score on a scale | Standard Deviation 14 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Function follow-up | 76.7 score on a scale | Standard Deviation 14.9 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Pain baseline | 60.9 score on a scale | Standard Deviation 14 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Pain follow-up | 57.7 score on a scale | Standard Deviation 14.6 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Function baseline | 71.2 score on a scale | Standard Deviation 13.2 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | Ql- follow up | 26.6 score on a scale | Standard Deviation 15.2 |
| Standard Neuromuscular Exercise and OA Education | Knee Injury and Osteoarthritis Outcome Score (KOOS) | QL baseline | 19.7 score on a scale | Standard Deviation 16.8 |
Mechanical Temporal Summation (TS)
A 512mN weighted probe was applied at the volar wrist opposite to the index knee. Participants were asked to rate their pain on a scale from 0 (no pain) to 100 (worst imaginable pain). Then, the same stimulus was applied 10 times at a rate of 1 per second (guided by a metronome), and participants were again asked to rate their pain. Temporal Summation (TS) was defined as present if the pain rating after the repeated stimuli was higher than the initial pain rating. The TS score was calculated as the difference between the pain rating after the repeated stimuli and the initial pain rating at each timepoint.
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Mechanical Temporal Summation (TS) | Follow-up | 1.6 score on a scale | Standard Deviation 1.4 |
| Pain Informed Movement and Pain Neuroscience Education | Mechanical Temporal Summation (TS) | Baseline | 1.8 score on a scale | Standard Deviation 1.6 |
| Standard Neuromuscular Exercise and OA Education | Mechanical Temporal Summation (TS) | Follow-up | 1.7 score on a scale | Standard Deviation 1.4 |
| Standard Neuromuscular Exercise and OA Education | Mechanical Temporal Summation (TS) | Baseline | 2.02 score on a scale | Standard Deviation 1.54 |
Modified Charlson Comorbidity Index
to assesses the presence of comorbidities minimum score = 0, maximum = 20 with higher scores indicating greater severity.
Time frame: baseline
Number of Participants With Medication Use
This outcome measure represents the number of participants who reported taking any medication on a regular schedule. Medication use was assessed with a yes/no response, where participants indicated whether they consistently take any prescribed or over-the-counter medications.
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Number of Participants With Medication Use | Baseline | 18 Participants |
| Pain Informed Movement and Pain Neuroscience Education | Number of Participants With Medication Use | 8 weeks | 16 Participants |
| Standard Neuromuscular Exercise and OA Education | Number of Participants With Medication Use | Baseline | 9 Participants |
| Standard Neuromuscular Exercise and OA Education | Number of Participants With Medication Use | 8 weeks | 10 Participants |
Other Painful Body Parts
Using a body diagram, participants will be asked to indicate any other areas where they experience pain
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Other Painful Body Parts | Baselin | 3.6 mean number of painful joints | Standard Deviation 2.8 |
| Pain Informed Movement and Pain Neuroscience Education | Other Painful Body Parts | 8 weeks | 4 mean number of painful joints | Standard Deviation 3.9 |
| Standard Neuromuscular Exercise and OA Education | Other Painful Body Parts | Baselin | 2.9 mean number of painful joints | Standard Deviation 1.9 |
| Standard Neuromuscular Exercise and OA Education | Other Painful Body Parts | 8 weeks | 2.36 mean number of painful joints | Standard Deviation 1.5 |
Pain Catastrophizing Scale (PCS)
13 questions for a total score of 52 with higher scores indicating more severe symptoms. Minimum score = 0, maximum score 52
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Pain Catastrophizing Scale (PCS) | Baseline | 11.2 score on a scale | Standard Deviation 9.6 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Catastrophizing Scale (PCS) | Follow-up | 7.4 score on a scale | Standard Deviation 7.4 |
| Standard Neuromuscular Exercise and OA Education | Pain Catastrophizing Scale (PCS) | Follow-up | 11.1 score on a scale | Standard Deviation 6.8 |
| Standard Neuromuscular Exercise and OA Education | Pain Catastrophizing Scale (PCS) | Baseline | 9.4 score on a scale | Standard Deviation 9.1 |
Pain Intensity Measured on the Numeric Rating Scale (NRS)
This outcome measure assesses pain intensity using the Numeric Rating Scale (NRS), where participants rate their pain on a scale from 0 to 10, with higher scores indicating greater pain severity. Three ratings are recorded: average pain intensity in the past 24 hours, average pain intensity in the past week, and worst pain intensity in the past 24 hours.
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow up Pain in the past 24 hours | 3.0 score on a scale | Standard Deviation 2.2 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow up worse pain in the past 24 hours | 3.5 score on a scale | Standard Deviation 2.7 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline worse pain in the past 24 hours | 4.9 score on a scale | Standard Deviation 1.8 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline Pain in the past 24 hours | 4.2 score on a scale | Standard Deviation 1.7 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow-up Pain in the past week | 3.3 score on a scale | Standard Deviation 1.6 |
| Pain Informed Movement and Pain Neuroscience Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline Pain in the past week | 4.2 score on a scale | Standard Deviation 1.4 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow-up Pain in the past week | 3.1 score on a scale | Standard Deviation 1.7 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline worse pain in the past 24 hours | 3.9 score on a scale | Standard Deviation 2.4 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow up Pain in the past 24 hours | 2.8 score on a scale | Standard Deviation 1.8 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline Pain in the past week | 3.8 score on a scale | Standard Deviation 1.9 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Follow up worse pain in the past 24 hours | 3.2 score on a scale | Standard Deviation 2.2 |
| Standard Neuromuscular Exercise and OA Education | Pain Intensity Measured on the Numeric Rating Scale (NRS) | Baseline Pain in the past 24 hours | 3.5 score on a scale | Standard Deviation 1.9 |
Participant Characteristics
Ethnicity
Time frame: baseline
Population: Ethnicity: Caucasian n (%)
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Participant Characteristics | 25 Participants |
| Standard Neuromuscular Exercise and OA Education | Participant Characteristics | 28 Participants |
Perspectives on Knee Replacement Surgery
Three questions will be asked: 1. Are your knee symptoms so severe that you wish to undergo knee replacement surgery? 2. Do you think knee replacement surgery is eventually inevitable? 3. In your opinion, what factor(s) can lead to better outcomes after knee replacement surgery?
Time frame: baseline and 8 weeks
Perspectives on the Effectiveness of the Different Intervention Components on Managing Pain
One question will be asked of participants in each arm to rank the effectiveness of the different components of the intervention they received. e.g. Please rank the different components of the intervention you received in order of how effective they are for managing your pain. A list of the different components in each study arm will be provided e.g. education videos, strengthening exercise, mind-body techniques
Time frame: 8 weeks
Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6)
measure of self-efficacy rated on 0-10 scale ranging from not at all confident to entirely confident
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6) | Baseline | 7.0 score on a scale | Standard Deviation 1.5 |
| Pain Informed Movement and Pain Neuroscience Education | Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6) | Follow-up | 7.4 score on a scale | Standard Deviation 1.9 |
| Standard Neuromuscular Exercise and OA Education | Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6) | Baseline | 6.8 score on a scale | Standard Deviation 1.8 |
| Standard Neuromuscular Exercise and OA Education | Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD-6) | Follow-up | 7.1 score on a scale | Standard Deviation 2 |
Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis
a neurotrophin level measured in pg/ml
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis | Baseline | 39.7 picograms per milliliter | Standard Deviation 8.9 |
| Pain Informed Movement and Pain Neuroscience Education | Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis | Follow-up | 40.3 picograms per milliliter | Standard Deviation 9 |
| Standard Neuromuscular Exercise and OA Education | Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis | Baseline | 39.3 picograms per milliliter | Standard Deviation 11.2 |
| Standard Neuromuscular Exercise and OA Education | Serum Levels of Brain Derived Neurotrophic Factors (BDNF) Via Blood Analysis | Follow-up | 39.1 picograms per milliliter | Standard Deviation 10.2 |
Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis
a neurotrophin level measured in pg/ml
Time frame: baseline and 8 weeks
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pain Informed Movement and Pain Neuroscience Education | Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis | Baseline | 614 picograms per milliliter | Standard Deviation 1436 |
| Pain Informed Movement and Pain Neuroscience Education | Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis | Follow-up | 587 picograms per milliliter | Standard Deviation 1460 |
| Standard Neuromuscular Exercise and OA Education | Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis | Baseline | 534 picograms per milliliter | Standard Deviation 1426 |
| Standard Neuromuscular Exercise and OA Education | Serum Levels of Nerve Growth Factor (NGF) Via Blood Analysis | Follow-up | 521 picograms per milliliter | Standard Deviation 1564 |
Weight
Weight
Time frame: baseline and 8 weeks